Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF Company Information
Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF's employee growth, exchange listings and data sources
Key Information
- Name: Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF
- Ticker: BIOTM
- Exchange: BATS-CHIXE
- Founded: NaN
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Market Cap: US$0
- Shares Outstanding: 0
- Website: https://fundcentres.lgim.com/uk/private/fund-centre/ETF/Pharma-Breakthrough
Location
- Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF
- One Coleman Street
- London
- Greater London
- EC2R 5AA
- United Kingdom
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| BIOT | LSE (London Stock Exchange) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | GB | USD | Jan 2018 |
| A2H9XR | DB (Deutsche Boerse AG) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | DE | EUR | Jan 2018 |
| BIOT | BIT (Borsa Italiana) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | IT | EUR | Jan 2018 |
| BIGT | LSE (London Stock Exchange) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | GB | GBP | Jan 2018 |
| BIOT | ENXTAM (Euronext Amsterdam) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | NL | EUR | Jan 2018 |
| ETLI | XTRA (XETRA Trading Platform) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | DE | EUR | Jan 2018 |
| BIOT | SWX (SIX Swiss Exchange) | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | CH | CHF | Jan 2018 |
| BIOTM | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | L&G PHARMA BREAKTHROUGH GO UCITS ETF CHF | GB | EUR | Jan 2018 |
| ETLI | DB (Deutsche Boerse AG) | PHARMA BREAKTHROUGH UCITS ETF USD ACC | DE | EUR | Feb 2018 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/06/27 20:10 |
| End of Day Share Price | 2023/03/30 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.